Print Page  |  Contact Us  |  Report Abuse  |  Sign In  |  Join ACAM
News & Press: Member News

National Institutes of Health awards funds for planning a second chelation study

Monday, September 28, 2015  
Share |

National Institutes of Health awards funds for planning a second chelation study

Dr. Gervasio Lamas, chairman of medicine and Chief of the Columbia University Division of Cardiology at Mount Sinai Medical Center of Florida was also the study chairman in the Trial to Assess Chelation Therapy (TACT).

MIAMI BEACH, Fla. , Sept. 28, 2015 /PRNewswire-USNewswire/ -- The National Center for Complementary and Integrative Health (NCCIH) of the National Institutes of Health (NIH) has awarded $800,000 to Mount Sinai Medical Center of Florida and the Duke Clinical Research Institute to initiate a planning year for the second Trial to Assess Chelation Therapy (TACT2). Chelation is a process by which a medication, such as edetate disodium, can "grab" toxic metals like lead or cadmium within the body - which are present in most individuals - and allow their removal in the urine.

READ COMPLETE ARTICLE

Community Search
Sign In


Forgot your password?

Haven't registered yet?

Calendar

9/14/2017 » 9/17/2017
ACAM 2017 Annual Meeting

Latest News
Online Surveys